MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Enzymes
| | | | | Tissue enhanced |
MIXL1 | Mix paired-like homeobox | Transcription factors
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
MZB1 | Marginal zone B and B1 cell-specific protein | Predicted secreted proteins
| | | | | Tissue enhanced |
NCR3 | Natural cytotoxicity triggering receptor 3 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
NUGGC | Nuclear GTPase, germinal center associated | | | | | | Tissue enhanced |
P2RY10 | Purinergic receptor P2Y, G-protein coupled, 10 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY8 | Purinergic receptor P2Y, G-protein coupled, 8 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PAPL | Iron/zinc purple acid phosphatase-like protein | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PARP15 | Poly (ADP-ribose) polymerase family, member 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
PNOC | Prepronociceptin | Predicted secreted proteins
| | | | | Tissue enhanced |
POU2AF1 | POU class 2 associating factor 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
PTCRA | Pre T-cell antigen receptor alpha | Predicted membrane proteins
| | | | | Tissue enhanced |
PTPN7 | Protein tyrosine phosphatase, non-receptor type 7 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
RGS13 | Regulator of G-protein signaling 13 | | | | | | Tissue enhanced |
RHOH | Ras homolog family member H | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
RNASE7 | Ribonuclease, RNase A family, 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
RP11-1070N10.3 | Uncharacterized protein | | | | | | Tissue enhanced |
RP11-296A16.1 | | | | | | | Tissue enhanced |
RP11-685N3.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
RP11-796G6.2 | Uncharacterized protein | | | | | | Tissue enhanced |
S100A2 | S100 calcium binding protein A2 | Cancer-related genes
| | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | | | | | | Tissue enhanced |
SCIMP | SLP adaptor and CSK interacting membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
SEPT1 | Septin 1 | | | | | | Tissue enhanced |
SEPT1 | Uncharacterized protein | | | | | | Tissue enhanced |
SERPINA9 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
SIRPG | Signal-regulatory protein gamma | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SLAMF1 | Signaling lymphocytic activation molecule family member 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLAMF6 | SLAM family member 6 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SNX20 | Sorting nexin 20 | | | | | | Tissue enhanced |
SNX22 | Sorting nexin 22 | | | | | | Tissue enhanced |
SP140 | SP140 nuclear body protein | Transcription factors
| | | | | Tissue enhanced |
SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | Transcription factors
| | | | | Tissue enhanced |
STAP1 | Signal transducing adaptor family member 1 | | | | | | Tissue enhanced |
TCF7 | Transcription factor 7 (T-cell specific, HMG-box) | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
TCL1A | T-cell leukemia/lymphoma 1A | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
TCL1B | T-cell leukemia/lymphoma 1B | | | | | | Tissue enhanced |
TESPA1 | Thymocyte expressed, positive selection associated 1 | | | | | | Tissue enhanced |
TIFAB | TRAF-interacting protein with forkhead-associated domain, family member B | | | | | | Tissue enhanced |
TIGIT | T cell immunoreceptor with Ig and ITIM domains | Predicted membrane proteins
| | | | | Tissue enhanced |
TLR9 | Toll-like receptor 9 | CD markers FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM156 | Transmembrane protein 156 | Predicted membrane proteins
| | | | | Tissue enhanced |
TNFRSF13B | Tumor necrosis factor receptor superfamily, member 13B | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TNFRSF17 | Tumor necrosis factor receptor superfamily, member 17 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TNFRSF9 | Tumor necrosis factor receptor superfamily, member 9 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
TNFSF8 | Tumor necrosis factor (ligand) superfamily, member 8 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
TTC24 | Tetratricopeptide repeat domain 24 | | | | | | Tissue enhanced |